The firm was Jefferies Financial Group, and the analyst most widely quoted in connection with the idea that airline passengers taking weight-loss drugs (like Ozempic or similar GLP-1 medications) could make flights cheaper — and thus airlines like United Airlines (UAL) more profitable — was Sheila Kahyaoglu, a Jefferies analyst.

The firm was Jefferies Financial Group, and the analyst most widely quoted in connection with the idea that airline passengers taking weight-loss drugs (like Ozempic or similar GLP-1 medications) could make flights cheaper — and thus airlines like United Airlines (UAL) more profitable — was Sheila Kahyaoglu, a Jefferies analyst.